Literature DB >> 2860474

Malformation of fetus conceived 4 months after termination of maternal etretinate treatment.

W Grote, D Harms, U Jänig, H Kietzmann, U Ravens, I Schwarze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2860474     DOI： 10.1016/s0140-6736(85)92344-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Persistent etretinate levels in plasma after changing the therapy to acitretin.

Authors:  W E Lambert; A P De Leenheer; J P De Bersaques; A Kint
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

Review 2.  [Drugs in pregnancy].

Authors:  K Knörr
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

3.  Risk classification systems for drug use during pregnancy: are they a reliable source of information?

Authors:  A Addis; S Sharabi; M Bonati
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.